• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > Our people

Our leadership

Home > Our people

Our leadership

Representing more than 30 nationalities, DNDi’s diverse global team includes around 250 staff who bring essential skills and experience from the academic, non-profit, private, and public sectors.

DNDi is led by a Leadership Team (marked with an * asterisk below). Our colleagues leading activities across DNDi programmes, departments, and regional offices are listed below.

 

Executive team

Loading...
Luis Pizarro, DNDi Executive Director (as of Sept 2022)
Luis Pizarro
Executive Director *
Thi Hanh Cao
Thi Hanh Cao
External Relations Director *
Michelle Childs
Michelle Childs
Policy Advocacy Director *
Amelia Folkes
Amelia Folkes
Chief of Staff *
Laurent Fraisse
Laurent Fraisse
Research & Development Director *
Samuel Kariuki
Samuel Kariuki
Continental Lead Africa and Eastern Africa Director *
Rudi Paye Profile Picture
Rudi Paye
Strategy and Operations Director *
Kavita Singh
Kavita Singh
Continental Lead Asia and South Asia Director *
Sergio Sosa Estani
Sergio Sosa-Estani
Continental Lead Americas and Latin America Director *

Regional leaders

Loading...
Delali Attiogbe Attipoe
Delali Attiogbe Attipoe
North America Director *
Chirac Bulanga
Chirac Bulanga Milemba
DR Congo Director *
Vanessa Daniel
Vanessa Daniel
South East Asia Director *
Daisuke Imoto
Daisuke Imoto
DNDi Japan (from April 2025) and Business Development Director*
Kaori Nakatani
Kaori Nakatani
Japan Director (until June 2025)*
Eric Stobbaerts
Eric Stobbaerts
International Development Director
Monique Wasunna
Monique Wasunna
DNDi Africa Ambassador

R&D

Loading...
FabianaAlves2019
Fabiana Alves
NTD Leishmaniasis-Mycetoma Cluster Director *
AURICH Beate_photo Jan 2025
Beate Aurich
Head of Drug Safety & Pharmacovigilance
Fabiana Barreira
Fabiana Barreira
Clinical Project and Medical Leader
Fabienne Benoist
Fabienne Benoist
Head of Regulatory Sciences *
Vincent Billoet
Vincent Billoët
Pharmaceutical Development Leader
Simon Bolo
Simon Bolo
Head of Leishmaniasis Access
Stéphanie Braillard 2023
Stéphanie Braillard
Non-Clinical Development Leader
EricChatelain2019
Eric Chatelain
Head of Drug Discovery Programme
Glaucia Cota
Glaucia Cota
Head of Visceral Leishmaniasis Clinical Programme *
Stephane Daffis
Stephane Daffis
Drug Discovery Leader
Jean-Yves Gillon
Jean-Yves Gillon
Head of Translation Sciences
Stephane Hugonnet
Stéphane Hugonnet
NTD HAT-Filarial-Chagas Cluster Director *
Wendy Keller
Wendy Keller
Head of Clinical Quality Assurance
Jadel Kratz
Jadel Kratz
Head of Discovery and R&D Partnership, Latin America
Janice Lee
Janice Lee
Access Leader, Viral Cluster
JuniorMatangila-2024.jpg
Junior Matangila
Head of Disease, HAT *
Florent Mbo
Florent Mbo Kuikumbi
Access Leader and HAT Platform Coordinator
CarolineMenetrey2019
Caroline Menétrey
Clinical Project Leader
FredericMonnot2019
Frédéric Monnot
Clinical Operations Director *
CharlesMowbray2019
Charles Mowbray
Discovery Director *
Wilfried Mutombo
Wilfried Mutombo Kalonji
Head of DRC Clinical Operations
Collins Mutua
Collins Mutua
Head of Biostatistics
Borna Nyaoke
Borna Nyaoke-Anoke
Head of Mycetoma Disease *
Maria Jesús Pinazo
María Jesús Pinazo
Head of Chagas disease *
Justine Odionyi
Justine Odionyi
Head of Disease, HIV *
Sandra Rembry
Sandra Rembry
Clinical Project Leader
IsabelaRibeiro2019
Isabela Ribeiro
Viral Diseases Cluster Director *
Stephen Robinson
Stephen Robinson
Pharmaceutical Development Director *
Ivan Scandale
Ivan Scandale
Discovery Leader
Andre Siqueira photo 2024
André Siqueira
Head of Dengue Global Programme *
Peter Sjo
Peter Sjö
Head of Drug Discovery Programme
Craig Tipple
Craig Tipple
Medical Director *

Policy Advocacy

Loading...
Rachel Cohen
Rachel M. Cohen
Senior Advisor, Global Policy Advocacy

External Affairs

Loading...
JamesArkinstall2019
James Arkinstall
Communications and Advocacy Director *
Patricia Caldwell
Patricia Caldwell
Head of External Relations
Anna Crago
Anna Crago
Head of External Relations
Ilan Moss
Ilan Moss
Head of Media and Content
Linet Otieno
Linet Otieno
Head of Communications

Operations

Loading...
Pascale Boulet
Pascale Boulet
Intellectual Property & Access Leader
Phouttasone Bouppha
Phoutthasone Bouppha
Head of Financial Control
Pascal Carpentier
Pascal Carpentier
Director of IST *
CARRION Maja_photo_White Background_2025-draft
Maja Carrion
Head of the Project Management Office and Expert in Implementation Science *
Denise Guimaraes
Denise Guimaraes
Head of Regional Operations, Latin America
Isabel Gutierrez
Isabel Gutierrez
Head of Legal Affairs
Dominique Junod Moser
Dominique Junod-Moser
Legal Affairs Director *
Olga Lacroix
Olga Lacroix
Head of Accounting
Anderson Leal
Anderson Leal
HR & Organization Director *
Amit Malik
Amit Malik
Head of Regional Operations, South Asia
MousumiMondal-2023
Mousumi Mondal
Head of Business Development
Fabrice Mulangu
Fabrice Mulangu
Head of Regional Operations, DRC
Mae Shieh
Mae Shieh
Head of Business Development
SuchiVERMA-2024.jpg
Suchi Verma
Head of HR and Organization
Laurence Vielfaure
Laurence Vielfaure
Finance and Planning Director *

Founder

Loading...
BernardPecoul2019
Bernard Pécoul
Founder

Connect and share

Follow us on social media to stay updated and help us share the stories of neglected patients.  

Linkedin Instagram Twitter Facebook Youtube
EM PORTUGUÊS
EN ESPAÑOL
Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License